1. Home
  2. SFST vs ENTA Comparison

SFST vs ENTA Comparison

Compare SFST & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southern First Bancshares Inc.

SFST

Southern First Bancshares Inc.

HOLD

Current Price

$56.52

Market Cap

421.9M

Sector

Finance

ML Signal

HOLD

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$13.29

Market Cap

486.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFST
ENTA
Founded
1999
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
421.9M
486.3M
IPO Year
1999
2013

Fundamental Metrics

Financial Performance
Metric
SFST
ENTA
Price
$56.52
$13.29
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$51.00
$20.40
AVG Volume (30 Days)
51.4K
244.7K
Earning Date
01-22-2026
02-09-2026
Dividend Yield
N/A
N/A
EPS Growth
96.33
N/A
EPS
3.75
N/A
Revenue
$115,139,000.00
$65,324,000.00
Revenue This Year
$11.98
$0.99
Revenue Next Year
$13.21
$0.19
P/E Ratio
$14.67
N/A
Revenue Growth
23.49
N/A
52 Week Low
$29.14
$4.09
52 Week High
$58.77
$17.15

Technical Indicators

Market Signals
Indicator
SFST
ENTA
Relative Strength Index (RSI) 59.38 48.17
Support Level $53.18 $12.45
Resistance Level $58.77 $13.03
Average True Range (ATR) 2.25 0.63
MACD 0.00 0.01
Stochastic Oscillator 76.04 61.11

Price Performance

Historical Comparison
SFST
ENTA

About SFST Southern First Bancshares Inc.

Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: